Prep (2026/2027) | Disease Processes & Evidence-
Based Drug Therapy Questions with Verified Answers |
100% Accuracy | Nursing Pharmacology Certification |
Graded A+
1. A patient with chronic heart failure is prescribed lisinopril. What is the primary
mechanism of action of this drug that makes it beneficial in heart failure?
A) Positive inotropic effect
B) Reduction of preload and afterload via vasodilation
C) Increase in heart rate to improve cardiac output
D) Blockade of beta-1 receptors in the heart
Correct Answer: B
Rationale: Lisinopril is an ACE inhibitor. It works by inhibiting the conversion of
angiotensin I to angiotensin II, a potent vasoconstrictor. This leads to vasodilation,
reducing both preload (venous return) and afterload (systemic vascular resistance),
thereby decreasing the workload on the failing heart. It does not have a direct positive
inotropic effect (A), does not increase heart rate (C), and is not a beta-blocker (D).
2. Which of the following pathological changes is the hallmark of stable angina
pectoris?
A) Complete occlusion of a coronary artery by a thrombus
B) Rupture of an atherosclerotic plaque with platelet aggregation
,C) Transient ischemia due to a fixed atherosclerotic plaque unable to meet increased
oxygen demand
D) Vasospasm of a coronary artery in the absence of significant atherosclerosis
Correct Answer: C
Rationale: Stable angina is typically caused by a fixed, significant atherosclerotic
obstruction in a coronary artery. During physical exertion or emotional stress, the
myocardium's oxygen demand increases, but the stenosed vessel cannot supply enough
blood flow, leading to transient ischemia. A and B describe acute coronary syndrome
(unstable angina/MI). D describes Prinzmetal's (variant) angina.
3. A patient on warfarin has an INR of 5.5. The patient is not bleeding. According
to evidence-based guidelines, what is the most appropriate initial management
step?
A) Administer Vitamin K 10mg IV immediately.
B) Withhold the next dose of warfarin and resume at a lower dose when INR is
therapeutic.
C) Administer fresh frozen plasma.
D) Withhold warfarin and consider administering low-dose oral Vitamin K.
Correct Answer: D
Rationale: For an INR >5.0 but <9.0 in a non-bleeding patient, guidelines recommend
withholding warfarin and considering the administration of low-dose oral Vitamin K (1-
2.5mg) to reduce the INR, especially if the patient is at high risk of bleeding. IV Vitamin
K (A) is for life-threatening bleeding or very high INRs. Fresh frozen plasma (C) is for
active bleeding.
,4. The pathophysiology of orthostatic hypotension in an elderly patient is most
directly related to which of the following?
A) Increased sympathetic nervous system response
B) Decreased baroreceptor sensitivity and venous pooling
C) Increased cardiac output
D) Enhanced renin-angiotensin-aldosterone system activity
Correct Answer: B
Rationale: With aging, baroreceptors become less sensitive. When a person stands,
gravity causes blood to pool in the lower extremities, reducing venous return and
cardiac output. In a healthy individual, the baroreceptor reflex would immediately cause
vasoconstriction and increased heart rate. In the elderly, this reflex is blunted, leading to
a significant drop in blood pressure.
5. A patient is prescribed a calcium channel blocker (amlodipine) for hypertension.
Which of the following adverse effects is most commonly associated with this class
of drugs?
A) Peripheral edema
B) Bradycardia
C) Constipation
D) Bronchospasm
Correct Answer: A
Rationale: Amlodipine is a dihydropyridine calcium channel blocker that primarily
affects vascular smooth muscle. Its potent vasodilatory effect can lead to fluid
extravasation into the interstitial space, causing peripheral edema (swelling of the ankles
and feet). Bradycardia (B) is more common with non-dihydropyridines like verapamil.
Constipation (C) is a hallmark of verapamil. Bronchospasm (D) is not a side effect of
CCBs.
, Section 2: Respiratory System
6. A patient with asthma is prescribed a low-dose inhaled corticosteroid (ICS) and
a long-acting beta-2 agonist (LABA) combination inhaler. What is the primary
rationale for combining these two drugs?
A) The LABA prevents the systemic absorption of the ICS.
B) The ICS increases the bronchodilatory effect of the LABA.
C) The LABA has an additive effect on airway inflammation.
D) The ICS reduces airway inflammation, and the LABA provides bronchodilation; they
are complementary and allow for lower steroid doses.
Correct Answer: D
Rationale: ICS are the cornerstone of asthma management for their anti-inflammatory
effects. LABAs are powerful bronchodilators. Combining them provides complementary
effects: reducing inflammation and relieving bronchoconstriction. This combination also
allows for a lower dose of ICS than might be needed with ICS alone, reducing the risk of
systemic side effects.
7. In the pathophysiology of Chronic Obstructive Pulmonary Disease (COPD), what
is the primary mechanism leading to airflow limitation?
A) Reversible bronchospasm due to allergen exposure.
B) Destruction of alveolar walls and loss of elastic recoil, combined with airway
inflammation.
C) Overproduction of thick, tenacious mucus.
D) Hypertrophy of bronchial smooth muscle.